Cargando…
Interleukin-1 is required for cancer eradication mediated by tumor-specific Th1 cells
The role of inflammation in cancer is controversial as both tumor-promoting and tumor-suppressive aspects of inflammation have been reported. In particular, it has been shown that pro-inflammatory cytokines, like interleukin-1α (IL-1α), IL-1β, IL-6, and tumor necrosis factor α (TNFα), may either pro...
Autores principales: | Haabeth, Ole Audun Werner, Lorvik, Kristina Berg, Yagita, Hideo, Bogen, Bjarne, Corthay, Alexandre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4760324/ https://www.ncbi.nlm.nih.gov/pubmed/26942052 http://dx.doi.org/10.1080/2162402X.2015.1039763 |
Ejemplares similares
-
Molecular profiling of tumor-specific T(H)1 cells activated in vivo
por: Lorvik, Kristina Berg, et al.
Publicado: (2013) -
Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer
por: Haabeth, Ole Audun Werner, et al.
Publicado: (2011) -
A model for cancer-suppressive inflammation
por: Haabeth, Ole Audun Werner, et al.
Publicado: (2012) -
Tumor-specific CD4(+) T cells eradicate myeloma cells genetically deficient in MHC class II display
por: Tveita, Anders, et al.
Publicado: (2016) -
How Do CD4(+) T Cells Detect and Eliminate Tumor Cells That Either Lack or Express MHC Class II Molecules?
por: Haabeth, Ole Audun Werner, et al.
Publicado: (2014)